Skip to main content
Year archive

Telix Pharmaceuticals Ltd — 2019 filings

All 77 regulatory filings released by Telix Pharmaceuticals Ltd (TLX) in 2019, sourced directly from the official regulator.

77 Filings
2019 Period
2019 filings (77)
Filing Released Lang
NDA Clinical Briefing Package Submitted to the US FDA 2 pages 189.3KB
Regulatory Filings
2019-12-26 English
Zircon P3 IND submitted to US FDA 2 pages 190.2KB
Regulatory Filings
2019-12-23 English
TLX101 for Brain Cancer IPAX-1 Study Update 15 pages 1.9MB
Regulatory Filings
2019-12-22 English
Telix and Vic Cancer Centre receive Cancer Australia grant 2 pages 193.8KB
Regulatory Filings
2019-12-18 English
Telix and ATONCO Partner for Bladder Cancer 2 pages 192.4KB
Regulatory Filings
2019-12-15 English
Webcast of CEO presentation to Jefferies Conference 1
Regulatory Filings
2019-11-24 English
CEO presentation to Jefferies London Healthcare Conference 31 pages 3.2MB
Regulatory Filings
2019-11-20 English
Appendix 3B - quotation of escrow shares, issue of options 13 pages 159.8KB
Regulatory Filings
2019-11-14 English
Ceasing as substantial holder - following release of escrow 2 pages 75.8KB
Regulatory Filings
2019-11-14 English
Change in substantial, dilution of voting due to Placement 3 pages 98.1KB
Regulatory Filings
2019-11-14 English
Change in substantial, dilution of voting due to Placement 3 pages 98.4KB
Regulatory Filings
2019-11-14 English
Program Update - Q3 2019 19 pages 2.8MB
Regulatory Filings
2019-11-03 English
Telix and AusHealth Partner for Lung, Ovarian Cancer 2 pages 142.3KB
Regulatory Filings
2019-10-29 English
Notice of release of securities from Mandatory Escrow 1
Regulatory Filings
2019-10-28 English
Appendix 4C - September 2019 quarter 5 pages 1.1MB
Regulatory Filings
2019-10-28 English
Sales Note to accompany Appendix 4C 2 pages 150.2KB
Regulatory Filings
2019-10-28 English
Telix and GE data - 68Ga supply for prostate cancer imaging 2 pages 140.9KB
Regulatory Filings
2019-10-13 English
David Cade appointed Chief Business Officer and Head of IR 2 pages 135.1KB
Regulatory Filings
2019-10-06 English
Telix to Acquire European Production Facility 2 pages 145.6KB
Regulatory Filings
2019-10-02 English
App 3B - issue of shares following exercise of options 13 pages 154.7KB
Regulatory Filings
2019-09-16 English
App 3Y - Change in interests following exercise of options 3 pages 100.3KB
Regulatory Filings
2019-09-16 English
Telix to Commence Renal Cancer Imaging Study in Japan 3 pages 145.4KB
Regulatory Filings
2019-08-29 English
FDA Pre-NDA Meeting Outcomes - TLX591-CDx illumet 3 pages 148.8KB
Regulatory Filings
2019-08-27 English
App 3B for issue of shares under SPP - correction at Q8 13 pages 172.9KB
Regulatory Filings
2019-08-22 English
Appendix 3B - issue of shares under Share Purchase Plan 13 pages 172.9KB
Regulatory Filings
2019-08-21 English
Appendix 4D and Financial Report for half-year to 30 June 19 27 pages 2.6MB
Regulatory Filings
2019-08-21 English
First Australian Patient Dosed in ZIRCON Phase III Trial 3 pages 175.1KB
Regulatory Filings
2019-08-19 English
Telix Pharmaceuticals announces results of successful SPP 2 pages 77.4KB
Regulatory Filings
2019-08-18 English
Telix and GenesisCare Commence Prostate Cancer Study 3 pages 192.9KB
Regulatory Filings
2019-08-07 English
ENHANCING Prostate Cancer Clinical Study - Investor Overview 10 pages 1.2MB
Regulatory Filings
2019-08-07 English
Collaboration with DKFZ for Image-Guided Prostate Surgery 3 pages 173.1KB
Regulatory Filings
2019-08-04 English
Telix and Merck Group Combination Therapy Collaboration 1
Regulatory Filings
2019-07-31 English
Lancet Publication Demonstrates Superiority of PSMA Imaging 2 pages 143.5KB
Regulatory Filings
2019-07-31 English
Appendix 4C - June 2019 Quarter 5 pages 352.3KB
Regulatory Filings
2019-07-30 English
Sales Note to Accompany June 2019 Quarter Appendix 4C 3 pages 230.2KB
Regulatory Filings
2019-07-30 English
Telix Share Purchase Plan Booklet 11 pages 261.2KB
Regulatory Filings
2019-07-28 English
Cleansing Notice under s708A Corporations Act 1 pag
Regulatory Filings
2019-07-23 English
Appendix 3B - issue of Placement Shares 13 pages 172.7KB
Regulatory Filings
2019-07-22 English
Prostate Imaging Agent - Positive EU Approval Consultation 3 pages 176.8KB
Regulatory Filings
2019-07-21 English
Japanese Regulatory Update for Renal Cancer Imaging Program 2 pages 167.8KB
Regulatory Filings
2019-07-18 English
Telix Receives $9.3m R&D Tax Refund 1 page 74.3KB
Regulatory Filings
2019-07-17 English
Telix announces completion of $40.0 million Placement 3 pages 181.1KB
Regulatory Filings
2019-07-16 English
Investor Presentation 32 pages 8.3MB
Regulatory Filings
2019-07-16 English
Telix Reports Positive Phase III Meeting with the FDA 4 pages 181.7KB
Regulatory Filings
2019-07-14 English
Trading Halt 2 pages 297.2KB
Regulatory Filings
2019-07-14 English
Telix and Grupo RPH LATAM Manufacturing and Distribution 3 pages 187.4KB
Regulatory Filings
2019-07-02 English
Telix and PI Medical Distribution Agreement for Netherlands 3 pages 185.0KB
Regulatory Filings
2019-07-01 English
CEO presentation to Macquarie Emerging Leaders Conference 25 pages 3.5MB
Regulatory Filings
2019-06-18 English
Telix and Monrol Manufacturing and Distribution Agreement 3 pages 242.5KB
Regulatory Filings
2019-06-12 English
Telix and Osaka University Extend Collaboration 3 pages 175.6KB
Regulatory Filings
2019-06-11 English
Telix to present to Jefferies Healthcare Conference 1
Regulatory Filings
2019-06-03 English
Presentation to Jefferies Healthcare Conference 28 pages 4.5MB
Regulatory Filings
2019-06-03 English
Telix and Emory collaborate on Prostate Cancer Imaging Trial 3 pages 178.0KB
Regulatory Filings
2019-05-30 English
Response to ASX Query Letter 5 pages 480.2KB
Regulatory Filings
2019-05-30 English
Prostate Imaging Program - Commercial and Regulatory Update 3 pages 176.5KB
Regulatory Filings
2019-05-27 English
Chairman's Address to AGM 3 pages 196.0KB
Regulatory Filings
2019-05-21 English
CEO's Address to AGM 12 pages 17.9MB
Regulatory Filings
2019-05-21 English
AGM Results of Meeting 3 pages 222.2KB
Regulatory Filings
2019-05-21 English
Appendix 4C - March 2019 Quarter 7 pages 528.4KB
Regulatory Filings
2019-04-28 English
Fractionated Prostate Cancer Therapy Published 3 pages 90.8KB
Regulatory Filings
2019-04-25 English
AGM Notice of Meeting and Proxy Form 36 pages 449.2KB
Regulatory Filings
2019-04-17 English
Non-Deal Roadshow Presentation March-April 2019 24 pages 3.9MB
Regulatory Filings
2019-03-25 English
Telix and Cyclotek Manufacture VisAct ImmunoPET Tracer 2 pages 86.0KB
Regulatory Filings
2019-03-20 English
cGMP Manufacturing of TLX250 Renal Cancer Therapy Complete 3 pages 86.8KB
Regulatory Filings
2019-03-19 English
EAU issues updated prostate cancer imaging guidelines 2 pages 84.6KB
Regulatory Filings
2019-03-17 English
ANMI Acquisition - Voluntary Escrow Shares to be released 1
Regulatory Filings
2019-03-05 English
Appendix 4G - Key to Governance Disclosures 11 pages 200.7KB
Regulatory Filings
2019-02-27 English
Corporate Governance Statement 9 pages 257.4KB
Regulatory Filings
2019-02-27 English
Appendix 4E - Summary of Results 1 page 144.5KB
Regulatory Filings
2019-02-27 English
Annual Report 2018 86 pages 3.1MB
Regulatory Filings
2019-02-27 English
Telix appoints Gabriel Liberatore as Group COO 1 pa
Regulatory Filings
2019-02-17 English
Appendix 4C - December 2018 quarter 7 pages 554.9KB
Regulatory Filings
2019-01-30 English
Telix Group Expands Prostate Imaging Capability through ININ 4 pages 380.2KB
Regulatory Filings
2019-01-23 English
Appendix 3B - issue of unlisted share options 13 pages 178.9KB
Regulatory Filings
2019-01-23 English
Detailed Program Update - January 2019 81 pages 5.9MB
Regulatory Filings
2019-01-08 English
Update - Acceleration of Prostate Cancer Therapy Program 4 pages 107.1KB
Regulatory Filings
2019-01-07 English
Investor Presentation and Program Update 19 pages 5.1MB
Regulatory Filings
2019-01-07 English